Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
05/2005
05/26/2005US20050113302 Cardioprotective protein (A3P) or A3 receptor-mediated cardioprotective protein isoform (A3PI) exhibiting an altered expression in cardiac tissue in response to exposure to an A3 agonist; useful for clinical screening, diagnosis, prognosis, therapy, and prophylaxis
05/26/2005US20050113295 Carboxamide and amino derivatives and methods of their use
05/26/2005US20050113294 Carboxamide and amino derivatives and methods of their use
05/26/2005US20050112721 Chimeric peptide immunogens
05/26/2005US20050112702 Receptor binding assay wherein binding to the CLLD8 protein identifies the compound as being an agonist or antagonist; antiallergens
05/26/2005US20050112692 Screening peptide library; incubation complexing
05/26/2005US20050112556 Drug screening; endogenous human retrovirus; protein or peptide expressed by said retrovirus
05/26/2005US20050112134 Compositions and methods employing alternative reading frame polypeptides for the treatment of cancer and infectious disease
05/26/2005US20050112089 Conjugate of biodegradable aliphatic polyester with TAT 49-57 peptide or peptide chain containing TAT 49-57 peptide and nanoparticle manufactured using the same
05/26/2005CA2545590A1 Template fixed beta-hairpin loop mimetics and their use in phage display
05/26/2005CA2545454A1 Adenocarcinoma specific antibody sam-6, and uses thereof
05/26/2005CA2544820A1 Bacterial expression of protease inhibitors and variants thereof
05/26/2005CA2534342A1 Amino acid prodrugs
05/25/2005EP1533025A2 Microwave-assisted peptide synthesis
05/25/2005EP1532262A2 Petide amidation process
05/25/2005EP1532171A1 Protein tyrosine phosphatase inhibitors
05/25/2005EP1532164A1 Template-fixed peptidomimetics with antibacterial activity
05/25/2005EP1532142A2 Polypeptide cleavage process
05/25/2005EP1531847A2 Pharmaceutical formulation
05/25/2005EP1531846A2 Conjugates of ligand, linker and cytotoxic agent and related compositions and methods of use
05/25/2005EP1531836A2 Polypeptide cleavage process
05/25/2005EP1417219A4 Libraries of conformationally constrained peptides, chiral azacrowns, and peptidomimetics and methods of making the same
05/25/2005EP1187914B1 A structured peptide scaffold for displaying turn libraries on phage
05/25/2005EP1097164A4 Processes for coupling amino acids using bis-(trichloromethyl) carbonate
05/25/2005EP0907370B1 Hla-a2.1 binding peptides and their uses
05/25/2005EP0888541B1 Cryptic peptides and method for their identification
05/25/2005EP0733060B1 Metal chelators
05/25/2005CN1620464A Peptides for the treatment of cancer associated with the human papilloma virus (hpv) and other epithelial tumors
05/25/2005CN1620174A Cellular telecommunication system
05/25/2005CN1203090C Cyclic bonding inhibitor
05/25/2005CN1203089C New compound
05/25/2005CN1203088C Peptide with affinity for clotting factor VIII
05/25/2005CN1202808C Skin and hair darkening composition
05/24/2005US6897289 Peptide synthesis procedure in solid phase
05/24/2005US6897030 CDNA sequence encoding porcine brain natriuretic peptide and related genes encoding canine and human peptides with natriuretic activity are disclosed. The gene is shown to make accessible the DNAs encoding analogous natriuretic peptides in
05/24/2005US6896884 Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases
05/19/2005WO2005045430A1 Screening combinatorial bead libraries for cancer ligands
05/19/2005WO2005044842A1 Peptide useful for diagnosis and therapy of tumors
05/19/2005WO2005044313A2 Conjugates of angiotensin ii and an imaging moiety
05/19/2005WO2005019247A3 Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy
05/19/2005WO2004111075A8 Alternative reading frame polypeptides for treatment
05/19/2005WO2004097406A3 Nϵ AND/OR Nα DERIVATIZED, METAL AND ORGANIC PROTECTED L-HISTIDINE FOR COUPLING TO BIOMOLECULES FOR HIGHLY EFFICIENT LABELING WITH [M(OH2)3(CO)3]+ BY FAC COORDINATION
05/19/2005WO2004094452A3 Macrocyclic isoquinoline peptide inhibitors of hepatitis c virus
05/19/2005US20050107601 Nucleotide sequences coding immunoglobulin fusion specific to heparan sulfate proteoglycans for use as diagnostic and therapeutic tool in treatment and prevention of neurodegenerative and cell proliferative disorders
05/19/2005US20050107585 Signal-1/signal-2 bifunctional peptide inhibitors
05/19/2005US20050107583 Transport peptides for controlled delivery of substances into cells; drug delivery
05/19/2005US20050107543 Fluoro linkers and their use as linkers for enzyme-activated drug conjugates
05/19/2005US20050107304 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
05/19/2005US20050107289 Anti-microbial peptides and compositions
05/19/2005US20050107288 e.g. (S)-2-(3,5-Difluorophenyl)-1-((3S,7S,13S,16S,19S)-13,16,17-trimethyl-2,6,12,15,18-pentaoxo-5-oxa-1,11,14,17-tetraaza-tricyclo[17.3.0.07,11]docos-3-ylcarbamoyl)-ethylammonium 2,2,2-trifluoroacetate
05/19/2005US20050106727 Peptides for enhanced cell attachment and growth
05/19/2005US20050106695 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
05/19/2005US20050106691 Process for the production of ramoplanin-like amide derivatives
05/19/2005US20050106647 Antibodies with increased affinities for anthrax antigens
05/19/2005US20050106625 Recombinant fusion proteins with high affinity binding to gold and applications thereof
05/19/2005US20050106158 Antigen mimotopes and vaccine against cancers
05/19/2005US20050106137 Chimeric peptide immunogens
05/19/2005CA2544214A1 Hla-dr-binding antigen peptide derived from wt1
05/18/2005EP1531159A1 Peptide useful for diagnosis and therapy of tumors
05/18/2005EP1530725A1 Materials and methods for inductions of immune tolerance
05/18/2005EP1285928B1 Antibiotics tripropeptins and process for producing the same
05/18/2005CN1617881A Chemical process
05/18/2005CN1616484A Novel cyclopeptide anti-tumor, anti-virus antibiotic active compound
05/18/2005CN1616483A A group of artificially synthetic antibacterial peptide and its preparing method and use
05/18/2005CN1616082A Use of compound methionine enkephalin as medicine for treating brain cancer, kidney cancer and liver cancer
05/18/2005CN1202125C Peptide immunogen, vaccine made thereof for curing allergic reaction and its preparation method
05/18/2005CN1202124C Artificial synthetic organic polypeptide compound and its use
05/18/2005CN1201819C Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens
05/17/2005US6893868 Homo-doubly labeled compositions for the detection of enzyme activity in biological samples
05/12/2005WO2005042699A2 Modified polypeptides with therapeutic activity and methods of use
05/12/2005WO2005042698A2 T cell epitopes useful in a hepatitis c virus vaccine and as diagnostic tools and methods for identifying same
05/12/2005WO2005042567A1 Rapamycin peptides conjugates: synthesis and uses thereof
05/12/2005WO2005042034A1 Peptides whose uptake by cells is controllable
05/12/2005WO2005042027A2 Antagonists of the bradykinin b1 receptor
05/12/2005WO2005041998A1 Peptide for promoting healing of fractures
05/12/2005WO2005041882A2 Molecules that selectively home to vasculature of premalignant or malignant lesions of the pancreas and other organs
05/12/2005WO2005009948A3 Peptide inhibitors of beta-lactamases
05/12/2005WO2004111240A3 Sequence for the bacillomycin d synthesis in bacillus amyloliquefaciens fzb42
05/12/2005WO2004108938A3 Peptide ligands of dendritic cells for nucleic acid vector targeting
05/12/2005WO2004087196A3 Methods and compositions for the inhibition of modulation of t cell costimulatory pathway by a pathogenic agent
05/12/2005WO2004018502A8 Compounds binding to p-selectin
05/12/2005US20050101762 Cyclic peptide for use as tool in transmembrane transport; drug delivery
05/12/2005US20050101526 Cyclic peptidomimetic urokinase receptor antagonists
05/12/2005US20050100973 Using synaptosomal associated protein-25 (SNAP-25) as tool to screen for clostridial toxin protease activity; food safety; detecting food poisoning
05/12/2005US20050100963 KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
05/12/2005US20050100590 Liposomes encapsulating anticancer drugs and use thereof in the treatment of malignant tumours
05/12/2005US20050100555 Synovial tissue binding peptide; amino acid sequence motifs; identify binding peptides by grafting tissue of first species into second having attenuated immunological response
05/12/2005US20050100507 Chemotactic peptide antagonists for imaging sites of inflammation
05/12/2005CA2545499A1 Antagonists of the bradykinin b1 receptor
05/12/2005CA2544731A1 Rapamycin peptides conjugates: synthesis and uses thereof
05/12/2005CA2543919A1 Peptides whose uptake by cells is controllable
05/12/2005CA2541856A1 Modified polypeptides with therapeutic activity and methods of use
05/11/2005EP1529056A2 Post-cleavage sulfur deprotection for convergent protein synthesis by chemical ligation
05/11/2005EP1528929A1 Novel use of lipopeptide preparations
05/11/2005EP1286590A4 Peptide analogs and mimetics suitable for in vivo use in the treatment of diseases associated with abnormal protein folding into amyloid, amyloid-like deposits or beta-sheet rich pathological precursor thereof
05/11/2005EP1165541B1 Dimeric compounds and as inhibitors of neuraminidase
05/11/2005EP1068224B1 Pharmaceuticals for the imaging of angiogenic disorders
05/11/2005CN1615368A Effectors of innate immunity
05/11/2005CN1615148A Methods and compositions for derepression of IAP-inhibited caspase
05/11/2005CN1615131A Method for identification of tumor targeting enzymes
1 ... 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 ... 423